Daniel J. Starks, a director at Abbott Laboratories ( NYSE: ABT ), acquired 10,000 shares of the company’s common stock on April 27, 2026, for a total value of $926,537, bringing his total shares holding to 6.75M. Separately, EVP and CFO Philip P. Boudreau disclosed several share-related transactions dated April 23, 2026, including an open-market purchase of 2,200 shares at $91.50 each, held indir...
Daniel J. Starks, a director at Abbott Laboratories ( NYSE: ABT ), acquired 10,000 shares of the company’s common stock on April 27, 2026, for a total value of $926,537, bringing his total shares holding to 6.75M. Separately, EVP and CFO Philip P. Boudreau disclosed several share-related transactions dated April 23, 2026, including an open-market purchase of 2,200 shares at $91.50 each, held indirectly through his spouse. Separately, Boudreau reports 71,172 common shares held directly after these transactions. The purchases come at a notable time, with Abbott stock trading near its 52-week low of $, reflecting a decline of roughly 29% so far this year. S&P Global ( SPGI ) CEO Martina Cheung purchased 2,322 shares of the company’s stock on Wednesday, April 29, at an average price of $429.93 per share, amounting to a total investment of $998,297.46. Following the transaction, Cheung’s holdings increased to 27,518 shares, valued at approximately $11.83 million, marking a 9.22% rise in her ownership stake. Scott Tozier, a director at International Paper ( IP ), acquired 10,000 shares of the company on May 1, 2026, for an estimated $313,009. Following the transaction, he owns a total of 10,025 shares of International Paper. President and CEO Christopher L. Winfrey purchased a total of 6,936 Charter ( CHTR ) Class A shares through open-market transactions on April 28, 2026, including a separate entry for 3,468 shares held by his spouse, at a weighted average price of about $172, lifting his direct stake to 74,409 shares. In a separate filing, director Wade Davis acquired 5,728 shares on April 28, 2026, at $173.72 per share. Additionally, Nair Balan purchased 1,000 shares at $175.46, bringing his total stake to 12,029 shares. UnitedHealth Group ( UNH ) executive Patrick Hugh Conway, CEO of Optum, disclosed an open-market sale of 800 shares of the company’s common stock at $355.00 per share. Following the transaction, he directly owns 17,804.991 shares. Jacqueline P. Canney...